# GPT 5.2 Review - Reviewer 3/3 (Parallel)

**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** medium
**Timestamp:** 2026-01-28T18:50:48.942448
**Review mode:** Parallel (3 independent reviewers)
**Response ID:** resp_0043be2671ec946800697a4bde1a74819484903e7be54cea42
**Tokens:** 16418 in / 5303 out
**Response SHA256:** 7e06b306b86e05c9

---

## Referee Report (top general-interest / AEJ: EP standard)

### Summary
The paper asks whether Extreme Risk Protection Order (ERPO) laws reduce suicide. Using a 1999–2017 state-year panel and staggered DiD (Callaway–Sant’Anna), the paper finds a *positive* association between ERPO adoption and total suicide (ATT ≈ +0.53 per 100k, SE 0.19), while TWFE yields a negative, insignificant estimate. The paper repeatedly cautions that (i) there are only 3–4 treated states, (ii) inference is unreliable, and (iii) reverse causality is likely.

At a top journal standard, the current draft is **not close**. The core barrier is not the choice of estimator (which is appropriate), but **credible identification and—especially—valid inference** with *three treated clusters* and very limited post-treatment support for late adopters. As written, the paper’s results are best viewed as descriptive correlations. A publishable paper would need a fundamentally stronger research design and/or much richer variation (e.g., extending the panel through the post-2018 wave, using firearm-suicide outcomes, and implementing few-treated-cluster-robust inference).

---

# 1. FORMAT CHECK

### Length
- The provided PDF text shows **~28 pages including appendices/figures/code notes** (pages visible through ~28).
- **Main text appears ~20 pages** (Intro through Conclusion ends around p. 20; references + appendices follow).  
- For AER/QJE/JPE/ReStud/Ecta style expectations, this is **short on core content** and does not provide the depth needed in design, diagnostics, and robustness. If the journal’s “25 pages excluding refs/appendix” rule is applied strictly, **this fails**.

### References coverage
- Methods: cites key staggered DiD papers (Callaway & Sant’Anna; Goodman-Bacon; Sun & Abraham; de Chaisemartin & D’Haultfoeuille; Borusyak et al.; Roth). Good.
- Domain: cites some ERPO literature (Swanson et al. CT; Kivisto & Phalen; RAND review). **But the policy/suicide/firearm literature is far from adequately covered** (see Section 4 below).

### Prose vs bullets
- Most sections are paragraph form. Variable definitions in appendix are bullet-pointed (appropriate).
- However, some parts read like a technical report and repeat caveats; the narrative arc is weak (see Section 5).

### Section depth (3+ substantive paragraphs each)
- **Introduction (Section 1):** yes (several paragraphs).
- **Institutional background (Section 2):** yes (multiple paragraphs).
- **Data (Section 3):** yes but could be more substantive on measurement and suppression, especially for firearm suicides.
- **Empirical strategy (Section 4):** yes, but the inference discussion (p. 10) is not adequate as implemented.
- **Results (Section 5):** thin; event study and robustness are described, but interpretation dominates over demonstration. Needs far more empirical substance.
- **Discussion (Section 6):** yes, but largely reiterates caveats rather than offering design improvements.

### Figures
- Figures shown have axes and appear to display data (event study, trends, map).  
- **Publication quality is not there**: fonts/legibility and clarity are closer to working-paper quality. Event-study figure (p. 28 screenshot) is readable but would not pass a top journal’s graphics bar without redesign.

### Tables
- Tables have real numbers and SEs (Tables 3–4). No placeholders.
- Table 4 notes IPW/OR/DR are identical because no covariates—this is a red flag about implementation (see below).

---

# 2. STATISTICAL METHODOLOGY (CRITICAL)

### a) Standard errors for every coefficient
- Main regression table (Table 3) reports SEs in parentheses for ATT and TWFE.  
- Robustness table (Table 4) reports SEs.  
- **However:** the event-study coefficients in Figure 1 are presented with analytical SE-based 95% CIs, but the paper does not provide a full coefficient table. This is not a “fail,” but it is incomplete.

### b) Significance testing
- CIs are shown, and SEs are provided.  
- **But** the paper itself states (Section 4.3; p. 10; repeated in Results/Notes) that conventional inference is unreliable with **only 3 treated clusters**. This is correct—and fatal if not addressed with valid methods.

### c) 95% confidence intervals
- Table 3 includes 95% CIs. Good.

### d) Sample sizes
- N is reported in Tables 3–4.

### e) DiD with staggered adoption
- The use of Callaway & Sant’Anna is appropriate and avoids classic TWFE contamination. **PASS** on estimator choice.

### The non-negotiable issue: inference with few treated clusters
The paper currently uses **standard clustered SEs** with **3 treated clusters** in the main spec (IN/CA/WA) and 4 if CT is included. This is not acceptable for a top journal.

AER/QJE/JPE/ReStud/Ecta editors/referees will require **design-based or small-sample-valid inference**, e.g.:
- **Randomization / permutation inference** over treatment timing or treated-state assignment (Fisher-style), explicitly addressing staggered adoption.
- **Conley–Taber (2011)**-style inference for DiD with few policy changes, implemented correctly for your ATT target.
- **Wild cluster bootstrap** with appropriate restrictions and reporting, but note: with *three treated clusters*, even wild bootstrap can be misleading; you need to justify the procedure carefully.
- **Aggregation to a smaller set of independent shocks** (not really feasible here), or—most realistically—
- **Expand the treated sample** by extending the panel beyond 2017 to include the 2018–2019 wave (which the paper itself recommends, but does not do).

**Bottom line:** Under the review criteria you gave (“A paper CANNOT pass review without proper statistical inference”), this paper **fails** because it does not implement a valid inference strategy for the few-treated-cluster setting. As written, it is **unpublishable** in a top outlet.

---

# 3. IDENTIFICATION STRATEGY

### Credibility
- Identification is extremely weak because:
  1. **Only three treated states** drive the main results (CT excluded; WA has one post-year).
  2. **Late-adopter cohorts have almost no post-treatment support** (CA: 2 years; WA: 1 year).
  3. The policy is plausibly **endogenous to trends in suicide and broader mental-health/gun-policy dynamics**. The paper asserts mass-shooting-driven adoption timing helps (p. 9), but this is not convincingly argued or validated empirically.
  4. Outcome is **total suicide**, not firearm suicide—the mechanism mismatch is severe.

### Assumptions discussed?
- Parallel trends is discussed and event-study plots are shown. Good in principle.
- However, the event study is too noisy to be persuasive, and with few treated units it is not diagnostically powerful.

### Placebos and robustness
- Robustness is mostly re-estimation with different CS options, log outcome, and dropping cohorts (Table 4).
- Missing are the robustness checks that matter most here:
  - **State-specific pre-trend modeling/sensitivity** (e.g., Rambachan–Roth bounds, or explicit deviations-from-parallel-trends sensitivity).
  - **Leave-one-treated-state-out** influence diagnostics reported systematically (especially since IN likely dominates).
  - **Permutation/placebo adoption dates** and **placebo treated states** to calibrate how unusual the estimated ATT is under the null with this small treated set.
  - **Alternative control-group constructions** (region-only, or matched controls), given treated states’ different baseline levels and trajectories.

### Conclusions vs evidence
- The paper is commendably cautious and repeatedly says the positive estimate likely reflects reverse causation.
- But then the contribution becomes unclear: if the core estimate is not credible and inference is invalid, the paper needs a different value proposition (e.g., *a credible design* or *a rich measurement contribution*).

### Limitations discussed?
- Yes, extensively (often to the point that they overwhelm the paper). This is honest, but it also signals the study is not yet ready.

---

# 4. LITERATURE (Missing references + BibTeX)

## (A) ERPO / firearm policy and suicide: key missing work
The ERPO literature cited is selective and incomplete, and the broader firearm-suicide policy literature is thin. At minimum, you should engage with:
1. **Luca, Malhotra & Poliquin (2017, PNAS)** on waiting periods and suicide/homicide.
2. **Anestis et al.** (multiple papers) on firearm laws and suicide (methodologically mixed, but widely cited).
3. **Siegel, Pahn, Xuan, et al.** on firearm laws and suicide (again, contested but relevant).
4. **Wintemute and coauthors** on California GVRO implementation and case series evidence (if you discuss California uptake).
5. Empirical work on **permit-to-purchase** and **background checks** and suicide outcomes (various authors; you cite Miller et al. 2012 but need more policy-evaluation papers).

## (B) Methods: few treated clusters + policy evaluation alternatives
You cite Conley–Taber and Cameron–Gelbach–Miller, but you need to cite and use modern guidance on “few treated” and “staggered adoption + permutation inference,” and also consider alternative estimators:
- **MacKinnon & Webb** on wild bootstrap with few clusters.
- **Rambachan & Roth** on parallel trends sensitivity (you allude to it but do not cite the core paper).
- **Arkhangelsky et al.** / **synthetic DiD** and **Augmented SCM** (Abadie et al. 2010 is cited, but not the subsequent SDID line).
- **Abadie, Diamond, Hainmueller (2015)** on inference for SCM.
- **Ferman & Pinto** on inference/DiD with few treated (depending on which exact paper you choose).

### Suggested BibTeX entries (non-exhaustive)

```bibtex
@article{LucaMalhotraPoliquin2017,
  author  = {Luca, Michael and Malhotra, Deepak and Poliquin, Christopher},
  title   = {Handgun Waiting Periods Reduce Gun Deaths},
  journal = {Proceedings of the National Academy of Sciences},
  year    = {2017},
  volume  = {114},
  number  = {46},
  pages   = {12162--12167}
}
```

```bibtex
@article{RambachanRoth2023,
  author  = {Rambachan, Ashesh and Roth, Jonathan},
  title   = {A More Credible Approach to Parallel Trends},
  journal = {Review of Economic Studies},
  year    = {2023},
  volume  = {90},
  number  = {5},
  pages   = {2555--2591}
}
```

```bibtex
@article{ArkhangelskyEtAl2021,
  author  = {Arkhangelsky, Dmitry and Athey, Susan and Hirshberg, David A. and Imbens, Guido W. and Wager, Stefan},
  title   = {Synthetic Difference-in-Differences},
  journal = {American Economic Review},
  year    = {2021},
  volume  = {111},
  number  = {12},
  pages   = {4088--4118}
}
```

```bibtex
@article{AbadieDiamondHainmueller2015,
  author  = {Abadie, Alberto and Diamond, Alexis and Hainmueller, Jens},
  title   = {Comparative Politics and the Synthetic Control Method},
  journal = {American Journal of Political Science},
  year    = {2015},
  volume  = {59},
  number  = {2},
  pages   = {495--510}
}
```

```bibtex
@article{MacKinnonWebb2017,
  author  = {MacKinnon, James G. and Webb, Matthew D.},
  title   = {Wild Bootstrap Inference for Wildly Different Cluster Sizes},
  journal = {Journal of Applied Econometrics},
  year    = {2017},
  volume  = {32},
  number  = {2},
  pages   = {233--254}
}
```

If you discuss California GVRO implementation, you should add a credible California GVRO empirical source (Wintemute et al. and/or peer-reviewed evaluations). I am not providing a BibTeX for a specific GVRO paper here because the exact “best” cite depends on which outcome you emphasize (case series vs petitions vs prevented harms); but you should cite at least one peer-reviewed California GVRO implementation/evidence paper rather than only general summaries.

---

# 5. WRITING QUALITY (CRITICAL)

### a) Prose vs bullets
- Mostly paragraphs; acceptable.
- However, the writing repeatedly foregrounds caveats (“inference unreliable,” “reverse causation likely”) without offering a constructive empirical path forward inside the paper. This makes the paper read like a negative result plus disclaimers rather than a compelling contribution.

### b) Narrative flow
- The motivation is clear and important.
- The arc breaks in Results/Discussion: the reader is told the estimates are likely non-causal, but then there is no replacement design that *is* credible. For a top journal, this is a deal-breaker: you must either (i) credibly identify an effect, or (ii) make a major measurement/data contribution, or (iii) provide a new design-based inference contribution. Right now it is none of these.

### c) Sentence quality
- Generally readable, but often repetitive and hedged. Tighten: fewer repeated cautions; more direct statements about what is learned.

### d) Accessibility
- Econometric choices are reasonably explained.
- Magnitudes are contextualized a bit (4% of mean). Good, but more policy relevance is needed (e.g., implied deaths per year; comparison to known secular trend).

### e) Figures/tables
- Tables are serviceable but not top-journal polished.
- Figures need redesign for publication: clearer event-time support, show how many cohorts contribute at each event time, and provide a clean style consistent with journal expectations.

---

# 6. CONSTRUCTIVE SUGGESTIONS (What would make this publishable?)

## A. Extend the data window (highest priority)
The paper ends in 2017, missing the wave of ERPO adoption that provides *actual identifying variation*. This is the main reason you have 3 treated clusters. A publishable version should:
- Extend to **at least 2022/2023** (CDC mortality is available), capturing many adopters.
- Redefine treatment timing carefully and handle partial-year exposure consistently (drop transition years or model exposure shares).

## B. Use firearm-specific suicide (or justify total-suicide with strong logic)
Given the mechanism, total suicide is a noisy proxy. A top-journal paper would either:
- Use **firearm-suicide rates** (CDC WONDER, restricted-use mortality microdata, or compiled state-year counts with appropriate suppression handling), and present total suicide as secondary; or
- Provide a strong conceptual and empirical argument for why total suicide is the correct estimand (unlikely here).

## C. Fix inference properly (non-negotiable)
With few treated clusters (even after extension, some cohorts may still be small), implement:
- **Randomization inference / permutation tests** tailored to staggered adoption.
- **Conley–Taber-style intervals** for average effects with few policy changes.
- Sensitivity analyses where inference is robust to serial correlation and small treated counts.

## D. Replace (or complement) DiD with designs that fit “few treated”
For the early adopters specifically, consider:
- **Synthetic control / augmented SCM** for Indiana and Connecticut (where long post-period exists), with transparent inference (placebo distribution across donor pool).
- **Synthetic DiD** (Arkhangelsky et al. 2021) which often performs well in policy panels.
- A **stacked event study** with careful cohort windowing and donor restrictions.

## E. Model treatment intensity (orders filed / granted), not only “law on books”
Your Section 2.2 correctly says binary treatment is inadequate. If you want a contribution even with few treated states:
- Collect annual county/state ERPO petition/order counts (where available).
- Estimate a dose-response (e.g., event study in intensity; IV using implementation grants/training rollouts if any exist).
- This would also address why California vs Indiana might differ.

## F. Clarify estimand and cohort support
- WA has one post-year; CA has two. In Table 3, the “aggregate ATT” obscures that your estimate is heavily driven by Indiana and by specific comparisons. Decompose and show:
  - Cohort-specific ATTs with honest uncertainty (even if wide).
  - Goodman-Bacon-style decomposition for TWFE is not enough; show **CS group-time cells** and their weights.

## G. Improve the “why adoption is plausibly exogenous” argument—or drop it
The claim that timing was driven by mass shootings (p. 9) is not a valid exogeneity argument for suicide trends without evidence. Either:
- Provide an adoption model / narrative with documentation showing adoption is orthogonal to suicide trends, or
- Stop implying exogeneity and instead frame the paper around *policy endogeneity and evaluation pitfalls*—but then the contribution must be methodological, with concrete solutions.

---

# 7. OVERALL ASSESSMENT

### Strengths
- Important policy question with clear motivation.
- Correct recognition that TWFE is problematic under staggered adoption; appropriate use of Callaway–Sant’Anna.
- Unusually transparent about limitations (few treated clusters, outcome mismatch, endogeneity).

### Critical weaknesses
1. **Inference is not valid for the setting** (3 treated clusters) and the paper does not implement the necessary randomization/permutation/Conley–Taber style procedures. This alone blocks publication.
2. **Identification is not credible** with the current sample and outcome; reverse causality is likely and not addressed with a stronger design.
3. **Outcome mismeasurement**: total suicide is too far from the mechanism; likely attenuation and interpretability problems.
4. **Insufficient empirical depth**: too little decomposition, too little exploration of which cohort drives results, too few meaningful falsification tests.
5. Contribution is unclear: the paper’s headline finding is framed as likely spurious, leaving no remaining core result.

### Specific, actionable improvements
- Extend through the post-2018 adoption wave; use firearm suicides; implement randomization inference; and/or switch to SCM/SDID for early adopters.

---

DECISION: REJECT AND RESUBMIT